Impact of ultrasound contrast agents in echocardiographic assessment of ischemic heart disease

Recent Patents on Cardiovascular Drug Discovery

Volumn 5, Issue 2, 2010, Pages 103-112

  Lønnebakken, Mai T ^a   Gerdts, Eva ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Echocardiography; Ischemic heart disease; Left ventricular function; Myocardial perfusion; Myocardial viability No reflow phenomenon; Stress echocardiography; Ultrasound contrast agents

Indexed keywords

ECHO CONTRAST MEDIUM; SONOVUE; CONTRAST MEDIUM;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANAPHYLAXIS; ARTICLE; BACKACHE; CONTRAST ECHOCARDIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DRUG HYPERSENSITIVITY; FLUSHING; HEADACHE; HEART ARREST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPOTENSION; IMAGE QUALITY; ISCHEMIC HEART DISEASE; MICROBUBBLE; NO REFLOW PHENOMENON; PRIORITY JOURNAL; RISK ASSESSMENT; SIDE EFFECT; STRESS ECHOCARDIOGRAPHY; SYNCOPE; URTICARIA; ANIMAL; CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC USE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; PATHOPHYSIOLOGY; TOXICITY;

ANIMALS; CARDIOVASCULAR DISEASES; CONTRAST MEDIA; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA;

EID: 77953767009     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489010791515403     Document Type: Article

References (101)

1. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL, et al. Contrast echocardiography: Evidence-based recommendations by European Association of Echocardigraphy. Eur J Echocardiogr 2009; 10: 194-212.
2. Mulvagh SL, Rakowski H, Vannan MA, Abdelmonheim SS, Becher H, Bierig SM, et al. American Society of Echocardiographyconsensus statement of the clinical applications of ultrasoniccontrast agents in echocardiography. J Am Soc Echocardiogr 2008;21: 1179-201.
3. Bhatia VK, Senior R. Contrast echocardiography: Evidence forclinical use. State of the art review. J Am Soc Echocardiogr 2008;21: 409-16.
4. Olszewski R, Timperley J, Szmigielski C, Monaghan M, Nihoyannopoulos P, Senior R, et al. The clinical applications ofcontrast echocardiography. Eur J Echocardiogr 2007; 8: s13-s23.
5. Dwivedi G, Senior R. Contrast dobutamine stress myocardialperfusion echocardiography: Current methodology and clinicalapplications. Eur J Echocardiogr 2006; 7(Suppl 2): 8-15.
6. Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R, et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease. The OPTIMIZE Trial. J Am Coll Cardiol Imaging 2008; 1: 145-52.
7. Hoffmann R, von Bardeleben S, ten Cate F, Borges AC, Kasprzak J, Firschke C, et al. Assessment of systolic left ventricular function:a multi-centre comparison of cineventriculography, cardiac reso-nance imaging, unenhanced and contrast enhanced echocardio-graphy. Eur Heart J 2005; 26: 607-16.
8. Malm S, Frigstad S, Sagberg E, Larson H, Skjaerpe T. Accurate and reproducible measurements of left ventricular volume and ejectionfraction by contrast echocardiography: A comparison with magneticresonance imaging. J Am Coll Cardiol 2004; 44: 1030-5.
9. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrastperfusion imaging and wall motion analysis during dobutaminestress echocardiography for the diagnosis of coronary arterydisease. J Am Coll Cardiol. 2004; 44: 2185-91.
10. Lønnebakken MT, Bleie Ø, Strand E, Staal EM, Nygård OK, Gerdts E. Myocardial contrast echocardiography in assessment of stable coronary artery disease at intermediate dobutamine-inducedstress level. Echocardiography 2009; 26: 52-60.
11. Hoffmann R, Borges AC, Kasprzak JD, von Bardeleben S, Firschke C, Greis C, et al. Analysis of myocardial perfusion or myocardial function for detection of regional myocardial abnormalities. Anechocardiography multicenter comparison study using myocardialcontrast echocardiography and 2D echocardiography. Eur JEchocardiogr 2007; 8: 438-48.
12. Balcells E, Powers ER, Lepper W, Belcik T, Wei K, Ragosta M, et al. Detection of myocardial viability by contrast echocardiographyin acute infarction predicts recovery of resting function and contractile reserve. J Am Coll Cardiol 2003; 41: 827-33.
13. Dwivedi G, Janardhanan R, Hayat SA, Swinburn JM, Senior R. Prognostic value of myocardial viability detected by myocardialcontrast echocardiography early after acute myocardial infarction. JAm Coll Cardiol 2007; 50: 327-34.
14. Hayat SA, Senior R. Myocardial contrast echocardiography in STelevation myocardial infarction: ready for prime time? Eur Heart J 2008; 29: 299-314.
15. Lim TK, Burden L, Janardhanan R, Ping C, Moon J, Pennell D, et al. Improved accuracy of low-power contrast echocardiographyfor the assessment of left ventricular remodeling compared withunenhanced harmonic echocardiography after acute myocardialinfarction: Comparison with cardiovascular magnetic resonance imaging. J Am Soc Echocardiogr 2005; 18: 1203-7.
16. Funaro S, La Torre G, Madonna M, Galiuto L, Scarà A, Labbadia A, et al. Incidence, determinants, and prognostic value of reverseleft ventricular remodelling after primary percutaneous coronaryintervention: Results of the acute myocardial infarction contrastimaging (AMICI) multicenter study. Eur Heart J 2009; 30: 566-75.
17. Dwivedi G, Janardhanan R, Hayat SA, Lim TK, Greaves K, Senior R. Relationship between myocardial perfusion with myocardialcontrast echocardiography and function early after acute myocardialinfarction for the prediction of late recovery of function. Int JCardiol 2008: doi:10.1016/j.ijcard.2008.11.052. [Epub ahead ofprint].
18. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrastperfusion echocardiography. Circulation 2005; 112: 1444-50.
19. Carpenter, A.P. Jr, Slack, G.C. Gas microsphere liposomecomposites for ultrasound imaging and ultrasound stimulated drugrelease. US20030044354 (2003).
20. Schneider, M., Yan, F., Garcel, N., Puginer, J., Barrau, M.-B., Bussant, P., Hybl, E., Bichon, D., Grenier, P. Ultrasound contrastagents and methods of making and using them. US7083778 (2006).
21. Porter, T.R. Perfluorocarbon ultrasound contrast agents comprising micro bubbles containing a filmogenic protein and a saccharide. US5695740 (1997).
22. McCulloch M, Gresser C, Moos S, Odabashian J, Jasper S, Bednarz J, et al. Ultraosund contrast physics: A series on contrastechocardiography. J Am Soc Echocardiogr 2000; 13: 959-67.
23. Reale A, Pizzuto F, Gioffrè PA, Nigri A, Romeo F, Martuscelli E, et al. Contrast echocardiography: Transmission of echoes to the leftheart across the pulmonary vascular bed. Eur Heart J 1980; 1: 101-106.
24. Phillips, P.J., Guracar, I. Adaptive contrast agent medical imaging. US7591788 (2009).
25. Sehgal, C.M. Method and apparatus to control microbubbledestruction during contrast-enhanced ultrasound imaging, and usestherefore. US20030092991 (2003).
26. Nayyar S, Magalski A, Khumri TM, Idupulapati M, Stoner CN, Kusnetzky LL, et al. Contrast administration reduces interobserver variability in determination of left ventricular ejection fraction inpatients with left ventricular dysfunction and good baselineendocardial border deliniation. Am J Cardiol 2006; 98:1110-4.
27. Hoff, L., O-Stensen, J., Frigstad, S., Eriksen, M. Ultrasoundimaging of tissue perfusion by pulse energy disruption of contrastagents. US6315730 (2001).
28. Leong-Poi H, Rim SJ, Le DE, Fisher NG, Wei K, Kaul S. Perfusionversus function: The ischemic cascade in demand ischemia.Implications of single-vessel versus multivessel stenosis. Circulation 2002; 105: 987-92.
29. Abdelmoneim SS, Dhoble A, Bernier M, Erwin PJ, Korosoglou G, Senior R, et al. Quantitative myocardial contrast echocardiographyduring pharmacological stress for diagnosis of coronary arterydisease: A systematic review and meta-analysis of diagnosticaccuracy studies. Eur J Echocardiogr 2009; 10: 813-25.
30. Ito, H., Nakajima, Y. Method of analyzing and displaying bloodvolume using myocardial blood volume map. US7285095 (2007).
31. Monaghan, M.J. Methods of and systems for examining tissueperfusion using ultrasonic contrast agents. US5255683 (1993).
32. Lang RM, Bierig M, Devereux RB, Flashkampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7(2): 79-108.
33. Crossman DC. The pathophysiology of myocardial ischemia. Heart 2004; 90: 576-80.
34. Leistad E, Ohmori K, Peterson TA, Christensen G, DeMaria AN. Quantitative assessment of myocardial perfusion during gradedcoronary artery stenoses by intravenous myocardial contrastechocardiography. J Am Coll Cardiol 2001; 37: 624-31.
35. Wei K, Mulvagh SL, Carson L, Davidoff R, Gabriel R, Grimm RA, et al. The safety of Definity and Optison for ultrasound imageenhancement: A retrospective analysis of 78 383 administeredcontrast doses. J Am Soc Echocardiogr 2008; 21: 1202-6.
36. Anantharam B, Chahal N, Chelliah R, Ramzy I, Ggani F, Senior R. Safety of contrast in stress echocardiography in stable patients and in patients with suspected acute coronary syndrome but negative12-hour troponin. Am J Cardiol 2009; 104: 14-8.
37. Tsutsui JM, Elhendy A, Xie F, O'Leary EL, McGrain AC, Porter TR. Safety of dobutamine stress real-time myocardial contrastechocardiography. J Am Coll Cardiol 2005; 45: 1235-42.
38. Aggeli C, Giannopoulos G, Roussakis G, Christoforatou E, Marinos G, Toli C, et al. Safety of myocardial flash-contrastechocardiography in combination with dobutamine stress testing fordetection of ischemia in 5250 studies. Heart 2008; 94: 1571-7.
39. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 guidelines update forpercutaneous coronary intervention: A report of the AmericanCollege of Cardiology/ American Heart Association Task Force onPractical Guidelines. Circulation 2006; 113: 166-286.
40. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Ferquency of stress testing to document ischemia priorto elective percutaneous coronar intervention. JAMA 2008; 300:1765-73.
41. Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D, et al. European Association ofEchocardiography. Stress Echocardiography expert consensusstatement-executive summary: European association of echo-cardiography (EAE) (a registered branch of the ESC). Eur Heart J 2009; 30(3): 278-89.
42. Douglas PS, Khandheria B, Stainback RF, Weissman NJ, Peterson ED, Hendel RC, et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stressechocardiography: A report. Circulation 2008; 117: 1478-97.
43. Pelikka PA, Nagueh SF, Elhendy AA, Kuehl CA, Sawada SG. American Society of Echocardiography. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am SocEchocardiogr 2007; 20: 1021-41.
44. Senior R, Monaghan M, Becher H, Mayet J, Nihoyannopoulos P. Stress echocardiography for the diagnosis and risk stratification of patients with suspected or known coronary artery disease: A criticalappraisal. Supp Br Soc Echocardiogr Heart 2005; 91: 427-36.
45. Picano E, Molinario S, Pasanisi E. The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: A meta-analysis. Cardiovasc. Ultrasound 2008; 6: 30.
46. Dolan MS, Riad K, EL-Shafei A, Puri S, Tamirisa K, Bierig M, et al. Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutaminestress echocardiography compared with coronary angiography intechnically difficult patients. Am Heart J 2001; 142: 908-15.
47. Dijkmans PA, Senior R, Becher H, Porter TR, Wei K, Visser CA, et al. Myocardial contrast echocardiography evolving as a clinicallyfeasible technique for accurate, rapid, and safe assessment of myocardial perfusion. The evidence so far. J Am Coll Cardiol 2006;48: 2168-77.
48. Lønnebakken MT, Gerdts E. Assessment of coronary arterystenoses by myocardial contrast stress echocardiography. Eur Cardiovasc Dis 2008; 4: 64-6.
49. Malm S, Frigstad S, Torp H, Wiseth R, Skjarpe T. Quantitativeadenosine real-time myocardial contrast echocardiography fordetection of angiographically significant coronary artery disease. JAm Soc Echocardiogr 2006; 19: 365-72.
50. Abdelmoneim SS, Mankad SV, Bernier M, Dhoble A, Hagen ME, Ness SA, et al. Microvascular function in takotsubo cardiomyo-pathy with contrast echocardiography: Prospective evaluation and review of literature. J Am Soc Echocardiogr 2009: 22: 1249-55.
51. Dounis V, Siegmund T, Hansen A, Jensen J, Schumm-Draeger PM, von Bibra H. Global myocardial perfusion and diastolic function areimpaired to a similar extent in patients with type 2 diabetes mellitus and in patients with coronary artery disease - evaluation by contrastechocardiography and pulsed tissue Doppler. Diabetologica 2006;49: 2729-40.
52. Infusino F, Lanza GA, Sestito A, Segueglia GA, Crea F, Maseri A. Combination of variant and microvascular angina. Clin Cardiol 2009; 32: 40-5.
53. Tsutsui JM, Xie F, Cloutier D, Kalvaitis S, Elhendy A, Porter TR. Real-time dobutamine stress myocardial perfusionechocardiography predicts outcome in the elderly. Eur Heart J 2008; 29: 377-85.
54. Vogel R, Indermühle A, Meier P, Seiler C. Quantitative stressechocardiography on coronary artery disease using contrast-basedmyocardial blood flow measurements: prospective comparison withcoronary angiography. Heart 2009; 95: 377-84.
55. Agati L, Tonti G, Pedrizzetti G, Magri F, Funaro S, Madonna M, et al. Clinical application of quantitative analysis in real-time MCE. Eur J Echocardiogr 2004; 5(Suppl 2): 14-20.
56. Trindade ML, Caldas MA, Tsutsui JM, Rosario MA, Rochitte CE, Nicolau JC, et al. Determination of size and transmural extent of acute myocardial infarction by real-time myocardial perfusionechocardiography: A comparison with magnetic resonance imaging. J Am Soc Echocardiogr 2007; 20: 126-35.
57. Lafitte S, Higashiyama A, Masugata H, Peters B, Strachan M, Kwan OL, et al. Contrast echocardiography can assess risk area and infarct size during coronary occlusion and reperfusion:experimental validation. J Am Coll Cardiol 2002; 39: 1546-54.
58. Greaves K, Dixon SR, Fejka M, O'Neill WW, Redwood SR, Marber MS, et al. Myocardial contrast echocardiography is superiorto other known modalities for assessing myocardial reperfusionafter acute myocardial infarction. Heart 2003; 89: 139-44.
59. Kloner RA, Ganote CE, Jennings RB. The "no-reflow"phenomenon after temporary coronary occlusion in the dog. J ClinInvest 1974; 54: 1496-508.
60. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K, et al. Lack of myocardial perfusion immediately after successfulthrombolysis. A predictor of poor recovery of left ventricularfunction in anterior myocardial infarction. Circulation 1992; 85:1699-705.
61. Kaul S. Evaluating the "no reflow" phenomenon with myocardialcontrast echocardiography. Basic Res Cardiol 2006; 101: 391-9.
62. Khumri TM, Nayyar S, Idupulapati M, Magalski A, Stoner CN, Kusnetzky LL, et al. Usefulness of myocardial contrastechocardiography in predicting late mortality in patients withanterior wall acute myocardial infarction. Am J Cardiol 2006; 98:1150-5.
63. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the "no reflow" phenomenon. Apredictor of complications and left ventricular remodelling inreperfused anterior wall myocardial infarction. Circulation 1996;93: 223-8.
64. Dwivedi G, Janardhanan R, Hayat SA, Lim TK, Senior R. Improved prediction of outcome by contrast echocardiographydetermined left ventricular remodelling parameters compared tounenhanced echocardiography in patients following acutemyocardial infarction. Eur J Echocardiogr 2009; 10(8): 933-40.
65. Mollema SA, Nucifora G, Bax JJ. Prognostic value of echocar-diography after acute myocardial infarction. Heart 2009; 95: 1732-45.
66. Galiuto L, Garramone B, Scar'a A, Rebuzzi AG, Crea F, La Torre G, et al. The extent of microvascular damage during myocardialcontrast echocardiography is superior to other known indexed of post-infarct reperfusion in predicting left ventricular remodelling.Results of the multicenter AMIC study. J Am Coll Cardiol 2008;51: 552-9.
67. Thanigaraj S, Schechtman KB, Perez JE. Improved echocardio-graphic deliniation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement. J Am Soc Echocardiogr 1999; 12: 1022-6.
68. Kaul S, Senior R, Firschke C, Wang XQ, Lindner J, Villanueva FS, et al. Incremental value of cardiac imaging in patients presenting tothe emergency department with chest pain without ST-segmentelevation: A multicenter study. Am Heart J 2004; 148: 129-36.
69. Greaves S. Role of echocardiography in acute coronary syndromes. Heart 2002; 88: 419-25.
70. Kang DH, Kang SJ, Song JM, Choi KJ, Hong MK, Song JK, et al. Efficacy of myocardial contrast echocardiography in the diagnosis and risk stratification of acute coronary syndrome. Am J Cardiol 2005; 96: 1498-502.
71. Rinkevich D, Kaul S, Wang XQ, Tong KL, Belcik T, Kalvaitis S, et al. Regional left ventricular perfusion and function in patientspresenting to the emergency department with chest pain and no ST-segment elevation. Eur Heart J 2005; 26: 1606-11.
72. Winter R, Gudmundsson P, Willenheimer R. Real-time perfusionadenosine stress echocardiography in the coronary care unit: Afeasible bedside tool for predicting coronary artery stenosis inpatients with acute coronary syndrome. Eur J Echocardiogr 2005; 6:31-40.
73. Senior R, Villanueva F, Vannan MA. Myocardial contrast echocardiography in acute coronary syndromes. Cardiol Clin 2004;22: 253-67.
74. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-STelevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
75. Vorlat A, Claeys MJ, De Raedt H, Gevaert S, Vandekerckhove Y, Dubois P, et al. TIMI risk score underestimates prognosis in unstable angina/non-ST segment elevation myocardial infarction. Acute Cardiac Care 2008; 10: 26-9.
76. Tong KL, Kaul S, Wang XQ, Rinkevich D, Kalvaitis S, Belcik T, et al. Myocardial contrast echocardiography versus thrombolysis in myocardial infarction score in patients presenting to the emergencydepartment with chest pain and a nondiagnostic electrocardiogram. J Am Coll Cardiol 2005; 46: 920-27
77. Jeetley P, Burden L, Greaves K, Senior R. Prognostic value of myocardial contrast echocardiography in patients presenting tohospital with acute chest pain and negative troponin. Am J Cardiol 2007; 99: 1369-73.
78. Tsutsui JM, Xie F, O'Leary EL, Elhendy A, Anderson JR, McGrain AC, et al. Diagnostic accuracy and prognostic value of dobutamine stress myocardial contrast echocardiography in patients withsuspected acute coronary syndrome. Echocardiography 2005; 22:487-95.
79. 99mTc-MIBI SPECT myocardial perfusion imaging in patients after percutaneous coronaryintervention. Eur J Nucl Med Mol Imag 2004; 31: 655-62.
80. Giedd KN, Bergmann SR. Myocardial perfusion imaging following percutaneous coronary intervention: The importance of restenosis, disease progression, and directed reintervention. J Am Coll Cardiol 2004; 43: 328-36.
81. Elhendy A, Tsutsui JM, O'Leary EL, Xie F, Majeed F, Porter TR. Evaluation of restenosis and extent of coronary artery disease inpatients with previous percutaneous coronary interventions bycontrast stress real-time myocardial contrast perfusion imaging. Heart 2006; 92: 1480-3.
82. Jensen J, Lagerqvist B, Aasa M, Sarev T, Nilsson T, Tornvall P. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold thepromise?. J Intern Med 2006; 260: 118-24.
83. Lønnebakken MT, Staal EM, Bleie Ø, Strand E, Nygård OK, Gerdts E. Quantitative contrast stress echocardiography in assessment of restenosis after precutaneous coronary intervention instable coronary artery disease. Eur J Echocardiogr 2009; 10(7):858-64.
84. Henneman MM, Schuijf JD, van der Wall EE, Bax JJ. Non-invasiveanatomical and functional imaging for the detection of coronary artery disease. Br Med Bull 2006; 79-80: 187-202.
85. Hesse B, Lindhart TB, Acampa W, Anagnostopoulos C, Ballinger J, Bax JJ, et al. EANM/ESC guidelines for radionuclide imaging of cardiac function. Eur J Nucl Med Mol Imaging. 2008; 35: 851-85.
86. Gerber BL, Raman SV, Nayak K, Epstein FH, Ferreira P, Axel L, et al. Myocardial first-pass perfusion cardiovascular magnetic resonance: history, theory, and current state of the art. J CardovascMagn Reson 2008; 10: 18.
87. Pilz G, Heer T, Harrer E, Ali E, Hoefling B. Clinical applications of cardiac magnetic resonance imaging. Minerva Cardioangiol 2009;57: 299-313.
88. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, et al. Prognostic value of multidetector coronary computedtomographic angiography for prediction of all-cause mortality. JAm Coll Cardiol 2007; 50: 1161-70.
89. Schuijf JD, van Werkhoven JM, Pundziute G, Jukema JW, Decramer I, Stokkel MP, et al. Invasive versus noninvasive evalua-tion of coronary artery disease. JACC Cardiovascular Imaging 2008; 1: 190-9.
90. Schuijf JD, Bax JJ, va der Wall EE. Anatomical and functionalimaging techniques: Basically similar or fundamentally different? Neth Heart J 2007; 15: 43-44.
91. Bhan A, Kapetanakis S, Rana BS, Ho E, Wilson K, Pearson P, et al. Real-time three-dimensional myocardial contrast echocardiography:Is it clinically feasible? Eur J Echocardiogr 2008; 9: 761-5.
92. Toledo E, Lang RM, Collins KA, Lammertin G, Williams U, Weinert L, et al. Imaging and quantification of myocardialperfusion using real-time three-dimensional echocardiography. JAm Coll Cardiol 2006; 47: 146-54.
93. Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasoundtargeted microbubble destruction for drug and gene delivery. ExpertOpin Drug Deliv 2008; 5: 1121-38.
94. Kaul S. Myocardial contrast echocardiography: A 25-yearretrospective. Circulation 2008; 118: 291-308.
95. Unger, EC, Wu, Y. Methods of imaging and treatment. US7329402(2008).
96. Feinstein SB. The powerful microbubble: From bench to bedside,from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 2004; 287: 450-7.
97. Kaufmann BA, Lindner JR. Molecular imaging with targetedcontrast ultrasound. Curr Opin Biotechnol 2007; 18: 11-6.
98. Kaufmann B, Lewis C, Xie A, Mirza-Mohd A, Lindner JR. Detection of recent myocardial ischemia by molecular imaging of P-selectin with targeted contrast echocardiography. Eur Heart J 2007; 28: 2011-7.
99. Spinelli M, Demitri C, Sannino A, Peruzzotti-Jametti L, Bacigaluppi M, Comi G, et al. Micro-Bubbles as drug deliverysystems in cerebrovascular diseases. Recent Pat Cardiovasc Drug Discov 2009; 4: 222-33.
100. Laing ST, McPherson DD. Cardiovascular therapeutic uses oftargeted ultrasound contrast agents. Cardiovasc Res 2009; 83: 626-35.
101. Slikkerveer J, Dijkmans PA, Sieswerda GT, Doevendans PA, vanDijk AP, Verheugt FW, et al. Ultrasound enhanced prehospitalthrombolysis using microbubbles infusion in patients with acute STelevation myocardial infarction: Rationale and design of theSonolysis study. Trials 2008; 9: 72.